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Abstract.  Cytotactin is an extracellular matrix glyco- 
protein with a  restricted distribution during develop- 
ment.  In electron microscopic images,  it appears as a 
hexabrachion with six arms extending from a central 
core.  Cytotactin binds to other extracellular matrix 
proteins including  a chondroitin  sulfate proteoglycan 
(CTB proteoglycan) and fibronectin.  Although cytotac- 
tin binds to a variety of cells including  fibroblasts and 
neurons,  in some cases it causes cells in culture to 
round up and it inhibits their migration. 
To relate these various effects of cytotactin on cell 
behavior to its binding  regions,  we have examined its 
ability to support cell-substrate adhesion and have 
mapped its cell-binding function onto its structure.  In 
a cell-substrate adhesion assay,  fibroblasts bound to 
cytotactin but remained round.  In contrast,  they both 
attached and spread on fibronectin.  Neither neurons 
nor glia bound to cytotactin in this assay.  In an assay 
in which cell-substrate contact was initiated by cen- 
trifugation,  however, neurons and glia bound well to 
cytotactin; this binding  was blocked by specific anti- 
cytotactin antibodies.  The results suggest that neurons 
and glia can bind to cytotactin-coated substrates and 
that these cells, like fibroblasts, possess cell surface 
ligands for cytotactin. 
After applying methods of limited proteolysis and 
fractionation,  these assays were used to map the bind- 
ing functions of cytotactin onto its structure.  Frag- 
ments produced by limited proteolysis were fraction- 
ated into two major pools: one (fraction I) contained 
disulfide-linked oligomers of a  100-kD fragment and 
two minor related fragments,  and the second (fraction 
II) contained monomeric 90- and 65-kD fragments. 
The 90- and 65-kD fragments in fraction II were 
closely related to each other and were structurally and 
immunologically distinct from the fragments in frac- 
tion I.  Only components in fraction I were recognized 
by mAb M1,  which binds to an epitope located in the 
proximal portion of the arms of the hexabrachion and 
by a polyclonal antibody prepared against a 75-kD 
CNBr fragment of intact cytotactin.  A  mAb (1D8) 
and a polyclonal antibody prepared against a  35-kD 
CNBr fragment of cytotactin only recognized compo- 
nents present in fraction II.  In cell-binding experi- 
ments,  fibroblasts, neurons,  and glia each adhered to 
substrates coated with fraction II, but did not adhere 
to substrates coated with fraction I.  Fab' fragments of 
the antibody to the 35-kD CNBr fragment strongly in- 
hibited the binding of cells to cytotactin, supporting 
the conclusion that fraction II contains a cell-binding 
region.  In addition,  Fab' fragments of this antibody in- 
hibited the binding of cytotactin to CTB proteoglycan 
and to fibronectin.  The binding of fibroblasts to com- 
ponents in fraction II and to intact cytotactin was also 
inhibited by peptides containing  the sequence RGD. 
These combined results suggest that a cell-binding site 
containing  the sequence RGD is present in the distal 
portion of the arms of the cytotactin hexabrachion near 
binding  sites for CTB proteoglycan and fibronectin and 
that the disulfide-bonded portion of the hexabrachion 
does not contain these sites. 
C 
ELL adhesion  plays a major role among the develop- 
mental processes leading to pattern formation.  Mole- 
cules involved in cell adhesion  include  cell-cell ad- 
hesion molecules (12) and cell-substrate adhesion molecules 
(SAMs; 44). 1 The protein cytotactin is a SAM with a char- 
acteristic and striking  distribution during  development (9, 
1. Abbreviations used in this paper: CTB proteoglycan, cytotactin-binding 
proteoglycan; SAM, cell-substrate adhesion molecule. 
22). In the chick embryo, it appears first during gastrulation, 
is later expressed in basement membranes of the developing 
neural tube (9), and is seen in neural crest cell pathways, in- 
cluding the rostral half of sclerotomal mesenchyme of each 
somite (40)  where neural  crest ceils accumulate.  At later 
times of development, cytotactin is present at high levels in 
the central  nervous  system and in a number of nonneuronal 
tissues,  especially around smooth muscle and  along  base- 
ment membranes of lung and kidney  (9). 
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(24) have revealed a six-armed structure with a central core, 
designated a hexabrachion (16).  Biochemical analyses sug- 
gest that cytotactin is a disulfide-linked oligomer (22). Al- 
though the polypeptide subunits  of cytotactin that are ex- 
pressed  during  development  in  different  organs  vary  in 
molecular mass, all of these polypeptides appear to be the 
products of a  single gene (26).  In cytotactin preparations 
from 14-d embryonic chicken brains similar to those used in 
the present studies, the predominant subunit had a molecular 
mass of 220 kD (22, 24). Molecules known as brachionectin 
(16,  17), and tenascin (or myotendinous antigen [4, 5, 42]) 
have subunit sizes and electron microscopic images that are 
similar to those of cytotactin, and they are probably closely 
related or identical proteins. 
A  variety  of experiments  in  vitro  have  suggested  that 
cytotactin is  involved in  cell adhesion,  regulation of cell 
migration, and pattern formation. Antibodies to cytotactin 
inhibit the binding of  dissociated neurons to glial monolayers 
(22) and they interfere with the migration of external granule 
cells out of the molecular layer in explants of cerebellar cor- 
tex (6). Cytotactin both binds fibronectin and has an inhibi- 
tory effect on the migration of neural crest cells on fibronec- 
tin in vitro (40); it may have an analogous effect  on these cells 
in vivo as they invade the rostral half of somites (40). 
The ability of cytotactin to bind to various cells and to 
other extracellular matrix proteins has been analyzed in de- 
tail in assays in which the molecule was coupled to micro- 
scopic  fluorescent beads  (23,  24).  Such cytotactin-coated 
beads bind to neurons and fibroblasts and to other beads that 
were coated either with  fibronectin or with the  so-called 
cytotactin-binding proteoglycan  (CTB  proteoglycan;  23). 
When soluble CTB proteoglyean is incubated with cytotac- 
tin-coated beads before mixing them with cells, the binding 
of the beads to the cells is strongly inhibited suggesting that 
an  interaction between  CTB  proteoglycan and  cytotactin 
blocks cytotactin binding to cells (23, 24). Soluble cytotactin 
itself blocks the binding of fibronectin-coated beads to cells 
in a similar manner (23). It has also been reported that tenas- 
cin inhibits the binding of cells to fibronectin (31). These var- 
ious molecules appear to be members of a network of ex- 
tracellular matrix proteins whose abilities to bind to cells 
may be altered by their mutual binding interactions. Other 
probable members of this SAM network include the various 
matrix proteoglycans which have been shown to inhibit cell 
attachment to fibronectin (36,  38). To understand this com- 
plex of interactions, it is important to study each individual 
protein in terms of its structure-function relationships. 
In the present study, we have examined further the ability 
of various cell types to attach to cytotactin-coated substrates 
and have compared these cell-binding properties of the intact 
molecule with those possessed by its proteolytic fragments. 
Although cells attached to cytotactin-coated substrates, this 
interaction did not promote cell spreading, in marked con- 
trast to interactions with fibronectin for which cell binding 
is accompanied by spreading. To map the binding functions 
of cytotactin onto its structure, we prepared and character- 
ized fragments of cytotactin produced by limited proteolytic 
cleavage. Cells were found to bind to a domain in the arms 
of the cytotactin hexabrachion that does not include the re- 
gion in which the polypeptide chains are linked by disulfide 
bonds. On the basis of these and other studies, we present 
a model in which the known functional and structural prop- 
erties of cytotactin are localized in particular regions of the 
molecule. 
Materials and Methods 
Reagents 
Cytotactin  and  CTB  proteoglycan were  purified  from  14-d  embryonic 
chicken brains (24).  Other reagents included human plasma fibronectin 
(New York Blood Center, New York,  NY), BSA (ICN Biomedical, Inc., 
Lisle, IL), deoxyribonuclease I, trypsin (2×  crystallized), and alpha-chy- 
motrypsin (3 x  crystallized) (Cooper Biomedical, Malvern, PA), Staphylo- 
coccus aureus  V8 protease (Miles Scientific, Naperville, IL), proteinase K 
(Beckman Instruments, Inc.,  Palo Alto, CA),  CNBr  (Aldrich Chemical 
Co., Milwaukee, WI), laminin and tissue culture media (Gibco Laborato- 
ries, Grand Island, NY), synthetic peptides (Peninsula Laboratories, Bel- 
mont,  CA),  Sephacryl  S-300  (Pharmacia  Fine  Chemicals,  Piscataway, 
N J), phenylmethylsulfonylfluoride (PMSF) (Eastman Kodak Co., Roches- 
ter, NY), guanidine-HCl ultra pure (Schwartz/Mann Biotech, Cleveland, 
OH),  Nal25I (New  England  Nuclear,  Boston,  MA),  and  Covaspheres 
(Duke Scientific Corp., Palo Alto, CA). Purified chondroitin 6-sulfate was 
provided by Drs. M. B. Mathews and J. A. Cifonelli (University of  Chicago, 
Chicago, IL) under National Institutes of Health contract AM-5-2205. 
Cells 
Fibroblasts (24),  neurons (1), and glia (21) were prepared from 10-d em- 
bryonic chickens, as previously described, except that ceils were dissociated 
with 20 Ixg/ml of trypsin in the presence of 1 mM CaCI2. 
Gravity Cell Attachment Assay 
To prepare protein-coated substrates, eight drops (2 I.d each in PBS) contain- 
ing different proteins or different concentrations of protein were placed in 
a circular array near the center of  a polystyrene dish in a humid atmosphere 
to prevent drying (Falcon 1008, Becton Dickinson Labware, Oxnard, CA). 
After 30 rain, the dish was washed three times with PBS containing 10 
mg/ml BSA and the last wash was kept in the dish until cells were added (1 h). 
1-2  x  105 cells in 250 111 of medium (1 mg/ml BSA, 50 ~tg/ml DNase I, 
DME) were placed in the middle region of dishes containing the adsorbed 
protein dots for 60 rain at 37°C in a  10% CO2 incubator. The dishes were 
washed four times with  PBS,  and the bound cells were fixed with  1% 
glutaraldehyde, observed by phase microscopy, and counted using a 20× 
objective and an eyepiece reticle. Cells were counted in four predetermined 
fields that combined represented 10%  of the dot area.  To quantitate cell 
spreading, attached ceils were examined using an inverted microscope and 
the number of phase-dark, polygonal, flattened cells determined visually 
(20). Examples of ceils that have attached and spread are shown in Fig. 2 
B, while cells that have attached but not spread are shown in Fig. 2 A. 
Centrifugation Cell Attachment Assay 
96-well polystyrene (Falcon 3910)  or polyvinyl chloride microtiter plates 
(Falcon 3911) with U-shaped wells were incubated with 40 lxl/well of pro- 
tein in PBS and the wells were washed and blocked with BSA as described 
above for the substrates used in the gravity assay. 200 I~1 of a cell suspension 
containing 1-5  x  104 cells was placed in each well and the plate was cen- 
trifuged at 250 g for 1 rain. The pattern of cells in each well was observed 
using dark field microscopy and interpreted in terms of a balance between 
centrifugal force and cell-substrate adhesion; on a nonadhesive substrate, 
centrifugal force predominates and cells are driven into a pellet at the bot- 
tom of the well. As the strength of cell-substrate adhesion increases, cells 
become more likely to bind to the substrate as they contact it. Therefore, 
the area covered by cells after centrifugation increases as the size of the cen- 
tral cell pellet decreases (see Figs. 3 and 6). 
Quantitation of  Proteins on Substrates 
To estimate the amount of protein that was associated with the substrate in 
cell-attachment assays, radioiodinated molecules were incubated on poly- 
styrene as described above for the gravity assay and the centrifugation assay. 
In both assays, similar levels of adsorption were obtained. The concentra- 
tions of the various solutions used to coat substrates and the resulting levels 
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nun2; 3.7 lag/ml, 1.5 ng/mm2; 6 ~tg/ml, 2.5 ng/mm2;  11 lag/ml, 4.6 ng/mm2; 
20 I~g/mi, 8.4 ng/mm2; 33 lag/ml,  14 ng/mm2; 100 lag/mi, 34 ng/mm2;  300 
lag/mi, 64 ng/mm2;  fraction I 10 lag/ml,  1 ng/mm2; fraction II 5 Ixg/ml, 0.5 
ng/mm~;  fibronectin 3.7  lag/ml,  1.6 ng/mm2;  11  lag/ml,  4.8  ng/mm2;  20 
lag/mi, 7.6 ng/mm2; 33  Ixg/mi,  13 ng/mm2; 100  lxg/ml,  23 ng/mm2;  300 
lag/nil,  45  rig/ram  2, and laminin 20 I.tg/ml, 4.1  ng/mm2;  100  lag/ml,  16 
ng/mm  2.  When labeled proteins were incubated with the substrate in the 
presence of 10 mg/ml of BSA, adsorption to the substrate was inhibited 
>90%.  To confirm that substrate-associated counts in these experiments 
represented labeled protein and not free iodine, the adsorbed material was 
quantitatively eluted with SDS, resolved on SDS gels (28), and found to 
contain  polypeptides  with  the  same  specific  radioactivity  (,~1  x  l0  s 
cpm/mg) as the starting material. 
ELISAs using the various  anti-cytotactin antibodies described below 
were also performed on these radiolabeled samples of cytotactin and frag- 
ments of  cytotactin that had been adsorbed to substrates. The combined data 
from the quantitative adsorption experiments described above and these 
ELISAs allowed the construction of a standardization curve that could be 
used to convert the results of ELISAs into protein concentrations on the sub- 
strate. This curve was used to estimate the levels of adsorbed cytotactin and 
fragments of cytotactin in the experiment shown in Fig. 7. 
Preparation of Cytotactin Fragments 
To prepare chymotryptic fragments, 500 ~tg of  cytotactin purified from 5,000 
14-d chicken embryo brains (24) was dissolved in 2 ml PBS/2 M urea and 
was incubated with 5 lag ct-chymotrypsin for 3 h at 37°C.  Proteolysis was 
stopped with 1 mM PMSF and the sample was fractionated by gel filtration 
using Sephacryl S-300 equilibrated with 4 M guanidine hydrochloride/0.1 
M  Tris (pH 7.6).  The major fragments of cytotactin were found in two 
regions of the eluate, a breakthrough peak called fraction I and a second 
peak with a K,v =  0.1 called fraction II. Samples to be analyzed in adhe- 
sion assays were dialyzed against PBS and stored at  -70°C. The protein 
concentration in solutions containing cytotactin or other SAMs was deter- 
mined using the method of Lowry (30). Because solutions containing frag- 
ments of cytotactin were very dilute, their concentrations were estimated by 
spectrophotometry at 230 nm, using a solution of intact cytotactin whose 
concentration had been determined by the Lowry method as a standard. 
CNBr fragments were prepared from 300 Ilg of cytotactin and resolved 
on an SDS gel containing 13.5 % polyacrylamide. After staining, the promi- 
nent 75-  and  35-kD  fragments were cut from the gel,  emulsified with 
Freund's adjuvant, and injected into rabbits in two equal aliquots. Injections 
were separated by a 2-wk interval. IgG and Fab' fragments were purified 
from the serum of these rabbits as previously described (2). 
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Figure 1.  Dose dependence of fibroblast attachment and spreading 
on oytotactin and fibronectin in the gravity assay. Fibroblasts were 
incubated with dishes coated with increasing amounts of cytotactin 
($,  o)  or  fibronectin  (A,  A).  Cell  attachment  (e,  A)  and  cell 
spreading  (o,  A) were quantitated  as described in Materials  and 
Methods. Points represent averages (n =  2) of cells bound or spread 
per 0.38 mm  2, and bar half-lengths are mean deviations. The con- 
centrations of protein solutions used to coat the dishes are indicated 
on the abscissa. 
Radioiodination 
Proteins were incubated with a final concentration of 150 lag/ml of chiora- 
mine T  and  1 mCi/ml of t2~I. After 5  min, 400 lag/ml  of sodium meta- 
bisulfite was added to stop the reaction and free iodine was removed by dial- 
ysis against PBS in tubing with a  12-14 kD cut-off. 
Ultracentrifugation 
S values for cytotactin and its chymotryptic fragments were determined by 
ultracentrifugation on glycerol gradients (15) using the indicated standards. 
The indicated molecules were reduced and alkylated by sequential incuba- 
tion with dithiothreitol (5 raM, 30 rain, 25°C) and iodoacetamide (15 raM, 
10 rain, 25°C). 
Peptide Mapping Techniques 
Intact cytotactin was radioiodinated using chloramine T and fractions I and 
II were prepared from this material as described above. Intact cytotactin and 
fractions I and II were resolved on SDS gels under reducing conditions, and 
the indicated components were located by autoradiography, were cut from 
the gels, and were digested and resolved for one-dimensional peptide maps 
by the method of Cleveland et al.  (7,  18) or for two-dimensional peptide 
maps by the method of Elder et al.  (14). 
Results 
Fibroblasts Attach but Do Not Spread on 
Cytotactin-coated  Substrates 
When fibroblasts were incubated with cytotactin-coated sub- 
strates in the gravity assay, cell attachment increased as the 
concentration of protein on the substrate increased (Fig.  1, 
solid circles). When the abilities of fibroblasts to attach to 
substrates coated with cytotactin or with fibronectin were 
compared, the concentration dependence was found to differ. 
Similar numbers of cells attached to high concentrations of 
each protein, but attachment increased more rapidly with 
fibronectin concentration (solid triangles) and reached a pla- 
teau well before a plateau was reached on cytotactin. 
Cytotactin- and fibronectin-coated substrates also differed 
in their ability to promote the spreading of attached cells. 
While ~80 % of the attached cells spread on fibronectin dur- 
ing the course of the assay (see Fig.  1, open triangles, and 
Fig.  2 B), essentially no bound cells spread on cytotactin 
(see Fig. 1, open circles, and Fig. 2 A). During longer incu- 
bations, cells began to spread on cytotactin, but never to the 
extent observed on fibronectin. These combined results sup- 
port the idea that cell-substrate adhesion and cell spreading 
are separable processes (19, 34). 
Cytotactin  Can Inhibit or Promote the 
Attachment of  Neurons or Glia to Substrates 
Depending on Assay Conditions 
Two assays were used to evaluate the effects of cytotactin on 
the attachment of neurons and gliato polystyrene substrates, 
an assay in which cells settle onto the substrate (gravity as- 
say) and an assay in which cell-substrate contact was initi- 
ated by centrifugation (centrifugation assay). Several labora- 
tories have previously used centrifugation assays to evaluate 
cell-substrate adhesion. These assays fall into two classes, 
those in which cells are centrifuged into flat-bottomed wells 
(10,  19,  32) and those in which cells are centrifuged into 
U-shaped or V-shaped wells (13, 27, 39). In assays using flat- 
bottomed wells, the initial centrifugation deposits all cells in 
a uniform distribution on any substrate; specific attachment 
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strates in the centrifugation assay. Substrates were prepared by in- 
cubation with the indicated concentrations of cytotactin (CT), lami- 
nin  (LM),  fibronectin  (FN),  or  with  only  the  BSA-containing 
blocking buffer (BSA). Wells were preincubated  for 30 min with 
medium containing 500 I~g/ml  of Fab' fragments; cells were then 
added without a change of medium and the centrifugation cell at- 
tachment assay performed as described in Materials and Methods. 
The anti-cytotactin antibody used in this experiment is the antibody 
to the 35-kD CNBr fragment of cytotactin characterized below in 
Fig. 4. 
Figure 2. Attachment of fibroblasts to cytotactin-coated substrates 
in the gravity assay. Fibroblasts were attached to substrates coated 
with cytotactin (A) or fibronectin (B) as described in Materials and 
Methods. The concentration of protein solutions used to coat these 
spots were 103 ~tg/ml for cytotactin and 10 ~tg/ml for fibronectin. 
Bar, 103 ~tm. 
is quantitated either by reversing the direction of centrifuga- 
tion or by washing the substrates under conditions of defined 
shear and determining the number of cells that remain at- 
tached. The main advantage of this assay is that by perform- 
ing a series of successively more stringent washes, precise 
quantitations of adhesive strengths can be made because the 
biophysical parameters of sedimentation and shear to which 
the cells are subjected are well defined.  Centrifugation as- 
says using U-shaped wells are based on the following obser- 
vations: (a) that cells centrifuged into U-shaped wells coated 
with nonadhesive proteins form a small pellet at the bottom 
of the well, and (b) that cells centrifuged onto adhesive sub- 
strates coat the entire bottom of the well. Presumably, cells 
that attach to the substrate are not dislodged by the centrifu- 
gal force while cells that do not attach are driven to the bot- 
tom of the well. 
In the current studies,  we chose to use a  U-shaped well 
centrifugation assay because it is easier and faster both to do 
and to score, yet provides a reliable determination of the rela- 
tive ability of cells to attach to various substrates. It requires 
only a single centrifugation in contrast to the fiat-bottomed 
well assay which  usually  requires  at least two steps.  The 
U-shaped well assay is reliably scored by visual inspection 
(see Figs. 3 and 6) as are hemagglutination assays (45). The 
scoring of fiat-bottomed well assays is somewhat more labor- 
ious, requiring that the number of cells attached to each well 
be individually determined. 
Using the gravity assay, neither neurons nor glia attached 
to substrates coated with cytotactin or BSA although they at- 
tached well to substrates coated with laminin or fibronectin 
(Table I).  When  neurons  were incubated  for much longer 
time periods, the number of cells that attached to cytotactin 
was less than the number that attached to regions treated only 
with BSA.  Moreover, fewer neurons were attached to sub- 
strates coated with both cytotactin and fibronectin than were 
attached to substrates coated with fibronectin alone, suggest- 
ing that cytotactin (which also binds to fibronectin [23]) had 
an apparent inhibitory effect on cell-substrate adhesion  in 
this assay. 
Although neurons did not attach to cytotactin-coated sub- 
strates in the gravity assay, the earlier observation (23) that 
cytotactin-coated beads bound to neurons in suspension sug- 
gested that these cells do express functioning  cell-surface 
receptors for cytotactin. In support of this idea, dose-depen- 
dent attachment of neurons  to cytotactin-coated substrates 
was observed in the centrifugation assay (Fig. 3); in this as- 
Table L Attachment of  Neurons and Glia to Extracellular 
Matrix Proteins in the Gravity Assay 
Molecule on substrate  Neurons  Neurons  Glia 
lh  24h  lh 
Fibronectin  242  +  30*  ND  280  -t-  25 
Laminin  226  +  20  ND  310  +  42 
Cytotactin  2  +  2  4  +  1  10  +  3 
"Background"  4  +  2  67  +  12  6  +  5 
Fibronectin and 
cytotactin  116  +  37  ND  ND 
Attachment assays were performed as described in Materials and Methods. Sub- 
strates  were prepared  by  incubation with solutions containing 20  Ixg/ml of 
fibronectin or laminin, or  100 p,g/ml of cytotactin. The substrate coated with 
both fibronectin and cytotactin was prepared by sequential adsorption in that or- 
der. Cells were incubated with substrates for the indicated time periods (1 or 
24  h).  Background attachment was determined for regions treated with the 
BSA-containing blocking buffer only. 
* Numbers are averages +  mean deviations (n =  2) and represent cells attached 
per 0.38 mm  2. 
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but not to substrates coated with BSA. As expected, anti- 
cytotactin Fab' fragments inhibited cell attachment to cytotac- 
tin-coated  substrates  but  not  to  laminin-coated  substrates 
(Fig. 3). Consistent with observations from other laborato- 
ries that, under certain assay conditions, central neurons at- 
tach poorly to fibronectin (35), neurons attached only weak- 
ly to fibronectin in the centrifugation assay.  Glial cells also 
attached to cytotactin in the centrifugation assay, and, in ad- 
dition, attached to fibronectin and laminin but not to BSA 
(Fig.  3).  Again,  only cell  attachment to cytotactin-coated 
substrates was inhibited by anti-cytotactin antibodies. 
These results indicate that specific attachment can occur 
when neurons or glial cells are centrifuged onto a cytotactin- 
coated  substrate.  Use  of  the  combined  assays  therefore 
allowed us to compare the ability of cytotactin and its frag- 
ments produced by limited proteolysis to promote the attach- 
ment of a variety of cells including fibroblasts, neurons, and 
glia. 
Chymotryptic Fragments of  Cytotactin 
To map the cell-binding function of  cytotactin to its structure, 
proteolytic fragments of cytotactin were prepared. In prelim- 
inary  experiments, digestion of cytotactin with trypsin or 
chymotrypsin under native conditions was found to have lit- 
de effect on the molecule. However, in the presence of 2 M 
urea,  chymotryptic  digestion  of  cytotactin  yielded  two 
classes of fragments that could be separated by gel filtration 
in guanidine-HC1 (Fig. 4 A). The material that eluted first, 
called fraction I, barely entered a 6 % polyacrylamide gel un- 
der nonreducing conditions (Fig.  4  B, lane 1); when ana- 
lyzed under reducing conditions, fraction I contained a sin- 
gle major 100-kD component and two minor components of 
85 and 75 kD (Fig. 4 B, lane 3). The second class of frag- 
ments, called fraction II, contained two prominent compo- 
nents,  90 and 65 kD,  whose mobilities were only slighdy 
affected  by reduction (Fig. 4 B, compare lanes 2 and 4). Two- 
dimensional peptide mapping experiments (not shown) indi- 
cated that the 90- and 65-kD components in fraction II were 
very similar in structure. 
These results are consistent with the idea that fraction I 
contains a disulfide-bonded oligomeric fragment of cytotactin 
while fraction II contains monomeric fragments of cytotac- 
tin.  To test this hypothesis directly, sedimentation velocity 
centrifugation was  used  to  estimate  the  native molecular 
masses of intact cytotactin, the material in fraction I, and the 
Figure 4. Structural properties 
of cytotactin fragments. Chy- 
motryptic fragments of cyto- 
tactin  were  prepared  as  de- 
scribed in Materials and Meth- 
ods, fractionated by gel filtra- 
tion on Sephacryl  S-300 in 4 M 
guanidine-HC1/0.1  M  Tris- 
HC1 (pH 7.6), and resolved by 
SDS-PAGE on 6% polyacryl- 
amide gels. (tl) Elution profile 
from  gel  filtration  column. 
The A230 of the  eluate  from 
the  gel-filtration  column  is 
plotted  vs.  fraction  number. 
Fractions  22-24  comprise 
"fraction I" and fractions 27- 
29 comprise "fraction II" (B) 
Silver-stained gels (33). 2-gg 
aliquots of fraction I (lanes 1 
and 3) and fraction II (lanes 2 
and  4)  were  resolved under 
nonreducing (lanes I and 2) or 
reducing (lanes 3 and 4) con- 
ditions.  (C-G) Immunoblots 
(41). 2-I.tg  aliquots of fraction 
I  (lanes 1)  and  fraction  II 
(lanes 2) were resolved under 
reducing  conditions,  trans- 
ferred to nitrocellulose,  and in- 
cubated with either a polyclonal 
antibody  prepared  against  a 
75-kD CNBr fragment of in- 
tact  cytotactin  (C),  mono- 
clonal  antibody  M1  (D),  a 
polyclonal antibody prepared 
against a  35-kD CNBr  frag- 
ment of intact cytotactin (E), 
monoclonal antibody 1D8 (F), 
or monoclonal antibody HNK-1 (G). Immunoblots incubated with monoclonal antibodies were further incubated with appropriate second 
antibodies (rabbit anti-mouse  IgG for M1 and  1D8, rabbit anti-mouse  IgM for HNK-I). All immunoblots were finally incubated with 
~25I-protein A and the position of this label was detected by autoradiography. 
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Estimated Molecular Masses for Cytotactin and 
Fragments of Cytotactin 
Form of Cytotactin  S Value (Estimated kD) 
Intact unreduced  13.2  +  0.7  (1,450) 
Reduced  7.5  ___  0.7  (225) 
Fraction I  unreduced  9.6  ___  1.3  (450) 
Reduced  3.6  +  0.4  (64) 
Fraction II unreduced  3.3  +  0.4  (58) 
Reduced  3.3  +  0.4  (58) 
S values were determined  by ultracentrifugation  on glycerol gradients  (15). 
Each gradient contained a radioiodinated form of cytotactin and the following 
unlabeled standard proteins: laminin, 11.5 S; fibronectin dimer, 10 S; fibronectin 
monomer, 7.5 S; IgG, 7 S; and BSA, 4.4 S. Gradient fractions were resolved 
by SDS-PAGE and the positions of standard proteins determined by Coomassie 
Blue staining and the position of forms of cytotactin by autoradiography. 
The  molecular  masses of forms of cytotactin  were  estimated  from  their 
S values using a conversion curve derived from the known S values (see above) 
and  molecular  masses  of standard  proteins  (laminin,  I  ×  106; fibronectin 
dimer,  4.4  ×  los;  fibronectin monomer,  2.2  ×  lOS; IgG,  1.5  ×  los;  BSA, 
6.8  ×  104). These  should only  be considered  rough  estimates  because  the 
conversion curve is derived from data for both fibrous and globular proteins, 
and because it is uncertain in what class each of the forms of cytotactin should 
be placed. Nevertheless,  a semilog plot of the molecular mass vs. S value for 
these standard proteins,  which include both classes,  is a good fit to a straight 
line. 
components in fraction II both before and after reduction and 
alkylation (Table II). Reduced intact cytotactin had a native 
molecular mass (225 kD) similar to its apparent molecular 
mass determined under denaturing conditions by SDS-PAGE 
(220 kD); the unreduced molecule had a native molecular 
mass approximately six times as great. These results support 
the idea that hexabrachions contain six polypeptide chains 
and further suggest that the formation of hexabrachions re- 
quires interchain disulfide bonds. 
Comparison of the material in fraction I before and after 
reduction suggested that it consisted of multiple polypeptide 
chains. The molecular masses obtained for this fragment of 
cytotactin under reducing and nonreducing conditions are 
consistent with the conclusion that it is hexameric; this con- 
clusion must be considered tentative, however, because the 
estimated native molecular mass for the reduced material (64 
kD) is considerably less than its molecular mass as estimated 
by SDS-PAGE (100 kD). In contrast to fraction I, the poly- 
peptides in fraction II did not change in molecular mass after 
reduction and apparently do not contain multiple subunits. 
The apparent native molecular mass of this material is also 
less (58 kD) than its molecular mass determined on poly- 
acrylamide gels under denaturing conditions (a mixture of 
90 and 65 kD components). This relationship is consistent 
with the idea that the components in both fraction I and frac- 
tion II have a rod-like shape. 
Immunological and Structural Characterization of 
the Fragments 
To determine the antigenic and structural relationships of the 
components in fractions I  and II and to evaluate whether 
these fractions were well separated by chromatography, ali- 
quots of fractions I  and II were immunoblotted with five 
different antibodies. These antibodies were a polyclonal anti- 
body (anti-35 kD) prepared against a 35-kD CNBr fragment 
of cytotactin, a polyclonal antibody (anti-75 kD) prepared 
against a 75-kD CNBr fragment of cytotactin which migrates 
as a multimer on SDS gels run under nonreducing condi- 
tions, and three monoclonal antibodies:  1D8, which recog- 
nizes a polypeptide epitope in cytotactin (26);  M1,  which 
binds to an epitope in the proximal part of the arms of the 
hexabrachion (17, 42); and HNK-1, which recognizes a car- 
bohydrate epitope present in cytotactin isolated from brain 
but not from other tissues (24). No molecular species com- 
mon to fractions I and II were detected by immunoblotting 
(Fig.  4,  C-G)  indicating  that  these  fractions  were  well 
resolved by chromatography. Both anti-75 kD and M1 recog- 
nized all the components in fraction I and no components in 
fraction II (Fig. 4,  C and D). Conversely, anti-35 kD and 
1D8 recognized components in fraction II and no compo- 
nents in fraction I (Fig. 4, E and F). Anti-35 kD recognized 
both major components in fraction II while  1D8 only ap- 
peared to recognize the 90-kD component. To confirm these 
results on native molecules, the antibodies were tested for 
their ability to recognize fractions I and II in an ELISA. As 
expected, anti-75  kD and  M1  were specific for fraction I 
while anti-35 kD and 1D8 were specific for fraction II. The 
anti-carbohydrate antibody, HNK-1, bound to all the compo- 
nents in both fractions I and I/, but to a greater extent to the 
components in fraction I (Fig. 4 G). An additional 120-kD 
component in fraction II was recognized by HNK-1 that was 
not detected with any other antibody. The fact that this spe- 
cies was  also not detected by silver staining  suggests that 
it is present at low levels and raises the possibility that it 
may be derived from cytotactin molecules that differ struc- 
turally from the majority of the cytotactin molecules in the 
preparation. 
To evaluate further the extent of structural overlap, if any, 
between the polypeptides in fractions I and II, the 100-kD 
fragment in fraction I and the 90-kD fragment in fraction II 
were prepared from radioiodinated cytotactin. After frac- 
tionation  by  SDS-PAGE  under  reducing  conditions,  gel 
slices  containing  the  fragments  were  treated  with  Staph. 
aureus V8 protease (Fig. 5) or proteinase K (data not shown) 
and  the  resulting  subfragments  resolved.  After treatment 
with either enzyme, the digestion products derived from the 
90-kD polypeptide were all of 10-30 kD (Fig. 5); almost no 
undigested material remained. In contrast, almost all of the 
fraction I  fragment migrated with  an  apparent molecular 
mass close to 100 kD after protease treatment; even when 
enzyme concentrations were increased fivefold, no further 
digestion was observed (not shown). These expriments indi- 
cate that the sites in the 90-kD polypeptide that are suscepti- 
ble to cleavage with V8 protease in SDS either are not present 
in the 100-kD polypeptide or are not accessible. Thus, it is 
likely that the 90- and  100-kD polypeptides correspond to 
different nonoverlapping parts of cytotactin. The combined 
antigenic and  structural data suggest that the fragment of 
cytotactin in fraction I is derived from the central core of the 
hexabrachion and extends somewhat into each arm of this 
structure, and that the species in fraction II are generated 
from the remaining distal portions of each arm of cytotactin. 
Cell Attachment to Substrates Coated with 
Chymotryptic Fragments of  Cytotactin 
The cell-binding properties of these chymotryptic fragments 
of cytotactin were then examined using the gravity assay for 
fibroblasts (Table III, A) and the centrifugation assay for neu- 
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teolytic  fragments  of  intact 
cytotactin,  fraction  I,  and 
fraction  II.  Cytotactin  was 
radioiodinated  using  chlora- 
mine T and fractions I and II 
were prepared from this mate- 
rial.  Radioiodinated  cytotac- 
tin, fraction I, and fraction II 
were resolved  by SDS-PAGE 
under reducing conditions and 
the  positions  of the  220-kD 
component of intact  cytotac- 
tin, the 100-kD component of 
fraction I, and 90-kD compo- 
nent  of fraction II were  de- 
termined by autoradiography. 
The pieces of polyacrylamide 
containing those polypeptides 
were cut  from the  gel,  their 
contents  digested  with 0.5  ~tg 
Staph. aureus V8 protease (7), 
and  the  digestion  products 
resolved  by SDS-PAGE on a 
15% polyacrylamide gel. Lane 
1,  intact  cytotactin;  lane  2, 
fraction I; Jane 3, fraction II. 
Note  that  essentially  all  the 
fragments produced by diges- 
tion of intact cytotactin appear 
in the digests of either fraction 
I or II. The migrations of stan- 
dard proteins  are indicated on 
the left. 
rons and glia (Fig. 6). In all cases, cells attached to substrates 
coated with the material in fraction II but not to substrates 
coated with the material in fraction I. A  greater percentage 
of attached fibroblasts spread on material in fraction II than 
on  intact  cytotactin,  but  the  extent  of spreading  was  still 
much less than on fibronectin (Table III, A). Two very differ- 
ent experiments confirm the idea that fraction II contains a 
specific cell-binding region while fraction I does not. (a) FalY 
fragments  of the  anti-35  kD  antibody  (which  recognizes 
only fraction II) strongly inhibited the attachment of cells to 
substrates coated with intact cytotactin or fraction II, while 
Fal¢ fragments of the anti-75 kD antibody (specific for frac- 
tion I) had no effect (Table III, A; and Fig. 6). As expected, 
the  anti-35  kD  antibody  did  not affect the  attachment  of 
fibroblasts to fibronectin (Table III, A) or neurons to laminin 
(Fig.  3).  (b) Soluble fraction lI was found to inhibit the at- 
tachment  of fibroblasts  to  a  substrate  coated  with  intact 
cytotactin while  fraction I  had no effect (Table III, B). 
Because the sequence Arg-Gly-Asp (RGD) is a functional 
part of the cell-binding  region of fibronectin and other ex- 
tracellular  proteins  (25,  37)  and  is  present  in the  primary 
structures  of cytotactin (26),  the effect of RGD-containing 
peptides on the attachment of cells to substrates coated with 
cytotactin or fraction II was examined. In the gravity assay, 
RGD-containing peptides inhibited the attachment of fibro- 
blasts to substrates coated with cytotactin or fraction II even 
more effectively than they inhibited the attachment of fibro- 
blasts to fibronectin (Table III, A).  Peptides containing the 
closely related  sequence  RGE had no effect on the attach- 
ment of fibroblasts to either cytotactin or fibronectin. These 
results suggest that RGD or a functionally related sequence 
is part of a  cell-binding region in cytotactin.  Nevertheless, 
in the centrifugation assay, RGD-containing peptides had no 
effect on  the  attachment  of neurons  or  fibroblasts  to  sub- 
strates coated with cytotactin or fraction II (Fig. 6). This re- 
sult  is  not likely to be a  methodological artifact  resulting 
from the use of the centrifugation assay because RGD-con- 
raining peptides were able to inhibit the attachment of fibro- 
blasts  to fibronectin  in  this  assay  (Fig.  6).  Therefore,  the 
results raise the possibility that fraction II of cytotactin may 
Table IIL Attachment of Fibroblasts to Cytotactin and Fraction H in the Gravity Assay 
A.  Inhibition by Specific Antibodies and Peptides in Solution 
Fab' fragments  Peptides 
Molecule 
on substrate  Unimmunized rabbit  Anti-35 kD§  Anti-75kD§  GRGDS  GRGESP 
Cytotactin  184  +  6" (0)*  4  ±  2  189  +  10  23  ±  7  155  ±  20 
Fraction  II  217  ±  5 (69  ±  22)  6  ±  2  205  ±  8  8  ___ 3  206  ±  27 
Fraction  I  6  ±  3 (0)  ND  ND  ND  ND 
Fibronectin  174  ±  33 (145  +  34)  166  ±  33  191  +  11  90  +  23  200  +  1 
-  5  ±2  7  ±  2  11  ±  1  11  ±4  5  ___  1 
B.  Inhibition  by Fragments of Cytotactin 
Molecule  Molecule 
on substrate  in solution  Bound ceils 
Cytotactin  -  223  +  50 
Cytotactin  Fraction  II  83  _  28 
Cytotactin  Fraction  I  230  +  15 
-  -  35+1 
Attachment assays were performed  as described  in Materials and  Methods. 
Substrates were prepared by incubation with solutions containing 100 Ixg/ml 
of cytotactin, 5  ~tg/ml of fraction I1, or  10 p.g/ml of fraction I or fibronectin. 
For antibody perturbation experiments, dishes were preincubated for 30 min 
with 50 gl of medium containing 500 V.g/ml of the appropriate Fab' fragments; 
cells were then added without a change of medium. In other perturbation ex- 
periments,  synthetic peptides (Peninsula Laboratories,  Inc.; GRGDS,  Code 
9137; or GRGESP,  Code 9135) at a  concentration of 1 mg/ml or fractions I 
or II at a concentration of 2 p.g/ml were preincubated with cells in medium for 
30 min before addition of the mixtures to the dishes. 
* Numbers are averages _+  mean deviations (n  =  2) and represent cells attached per 0.38  mm% 
Number of spread cells. 
§ Anti-cytotactin antibodies. 
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Figure 7. Specific binding activities of cytotactin and fraction II. In- 
creasing amounts of unreduced cytotactin  (x), reduced cytotactin 
(e), and fraction II (o) were adsorbed to the substrate.  Replicate 
spots bearing adsorbed protein were used either in fibroblast attach- 
ment experiments  (gravity assay) or in ELISA assays to estimate the 
amount of adsorbed protein as described in Materials and Methods. 
Adsorbed protein is expressed  in moles of polypeptide per cm  2. 
Points  represent  averages  (n  =  2) of cells  bound per 0.38  mm2; 
and bar half-lengths  are mean deviations. 
Figure 6. Inhibition of cell  attachment  in the centrifugation  assay 
by region-specific  antibodies  and  synthetic  peptides.  Substrates 
were prepared by incubation  with the indicated  concentrations of 
cytotactin (CT), the proteolytic fragments of cytotactin  in fraction 
I (Fr I) or fraction II (Fr H), or fibronectin (FN). For antibody per- 
turbation experiments,  wells  were  preincubated  for 30 min with 
medium containing  500 Ixg/ml of Fab' fragments; ceils  were then 
added without a change of medium. For peptide  perturbation ex- 
periments,  GRGDS or GRGESP (see Table III) at a concentration 
of  500 Ixg/ml  were incubated with cells in medium for 30 min before 
addition of  the mixtures to the wells. The centrifugation  cell attach- 
ment  assay  was  then  performed  as  described  in  Materials  and 
Methods. 
contain separate binding sites involved in RGD-sensitive and 
RGD-insensitive cell attachment. 
When the specific activities of intact cytotactin and frac- 
tion II were compared on a molar basis, fraction II was found 
to promote cell attachment at 20-fold lower concentrations 
than did intact cytotactin (Fig. 7). Cytotactin monomers (i.e., 
reduced  cytotactin)  were  also  somewhat more active than 
hexabrachions  in  supporting  cell-substrate  adhesion.  The 
apparent low specific activity of intact cytotactin relative to 
fraction II may result from the effects of steric hindrance on 
the availability of celt-binding sites when hexabrachions ad- 
sorb  to plastic.  Alternatively,  the binding of fraction II to 
cells  may,  in fact,  be more avid than the binding of intact 
cytotactin due to the release of  conformational restraints near 
the binding  sites. 
Localization of  Binding Sites in Cytotactin for 
CTB Proteoglycan and Fibronectin 
Previous  observations  suggested  that  CTB  proteoglycan 
binds  to cytotactin thereby  inhibiting  its  ability  to bind  to 
cells  (23).  We  therefore  examined  the  effects  of the  pro- 
teoglycan  on  the  attachment  of  fibroblasts  to  substrates 
coated with cytotactin or fraction II (Table IV). Soluble CTB 
proteolgycan inhibited the attachment of fibroblasts to frac- 
tion II by over 80 %, to intact cytotactin by -,40 %,  but had 
little effect on the attachment of ceils to fibronectin.  Chon- 
droitin sulfate did not affect cell attachment to cytotactin or 
its  fragment,  indicating that the inhibition  caused by CTB 
proteoglycan was not simply due to effects from the negative 
charge of the chondroitin sulfate in the proteoglycan. To dis- 
tinguish whether the inhibition  of binding to the cytotactin 
fragment was due to binding of the proteoglycan to the frag- 
ment itself or to cells,  CTB proteoglycan was preincubated 
either with fraction II-coated substrate or with the cells and 
then washed out before the incubation of the cells with the 
substrate.  Preincubation  of the  substrate  with  CTB  pro- 
teoglycan strongly inhibited the attachment of fibroblasts to 
fraction II while preincubation  of the cells  with CTB pro- 
teoglycan had little effect (Table V).  These experiments are 
consistent with the notion that CTB proteoglycan inhibits the 
attachment of fibroblasts  to cytotactin-coated substrates  by 
binding to a domain in cytotactin that,  like the cell-binding 
domain,  is located within fraction II. 
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Soluble molecule 
CTB  Chondroitin 
Molecule on substrate  None  proteoglycan  6-sulfate 
Cytotactin  201  5:  22*  122  5:10  243  5:45 
Fraction II  310  5:17  51  5:7  281  5:32 
Fibronectin  404  +  89  365  5:34  412  5:31 
-  165:7  12_+2  85:3 
Attachment assays were performed as described in Materials and Methods. Substrates were prepared by incubation with solutions containing 100 lag/ml of cytotac- 
tin, 5 Bg/ml of fraction II, or 10 Bg/ml of fibronectin. 50-BI drops of medium containing CTB proteoglycan (5 lag) or chondroitin 6-sulfate (5 lag) were incubated 
in dishes for 15  min; cells were then added without a change of medium. 
* Numbers are averages  +  mean deviations (n  =  2) and represent cells bound per 0.38  mm  2. 
To confirm the localization of the binding sites for CTB 
proteoglycan and fibronectin in the cytotactin molecule, the 
four antibodies specific for either fraction I or II were tested 
for their ability to perturb the binding of cytotactin-coated 
beads  to either CTB proteoglycan-coated beads or fibro- 
nectin-coated beads (Table VI). Both intermolecular binding 
mechanisms were strongly inhibited by low doses of Fab' 
fragments of the anti-35  kD antibody while even fivefold 
higher doses of  the anti-75 kD antibody had no effect. Mono- 
clonal antibodies 1D8 and M1 had little or no effect on bind- 
ing. Therefore, these results indicate that the binding sites in 
cytotactin for cells, CTB proteoglycan, and fibronectin are 
all in the  same general region of the molecule.  However, 
given the large stretch of polypeptide that might be blocked 
by an antibody molecule, it cannot be concluded that all three 
binding sites are located within the 35-kD CNBr fragment 
of cytotactin. It will be necessary to use higher resolution 
methods to determine the exact physical relationships among 
these three binding sites. 
Discussion 
In the present study, we have investigated the effects of cy- 
totactin on cell-substrate adhesion and cell shape, and have 
characterized a fragment of the molecule that contains the 
Table V. Reversibility  of the Effects of CTB 
Proteoglycan  on the Attachment of  Fibroblasts 
to Fraction H in the Gravity Assay 
Molecule on substrate  Soluble molecule  Attached cells* 
Fraction II  -  272:1:28 
Fraction II  CTB proteoglycan  58  5:15 
Fraction II  CTB proteoglycan, incubated 
with dish and washed out  104  5:32 
Fraction II  CTB proteoglycan, incubated 
with cells and washed out  214  5:18 
-  -  95:1 
Attachment  assays were performed  as described  in Materials  and Methods. 
Substrates were prepared  by incubation with solutions containing 5 Bg/ml of 
fraction II. 50-1tl drops of medium alone or medium containing CTB proteo- 
glycan (5 Bg) were incubated in dishes for 15 rain before introduction of cells. 
The indicated dishes were washed by changing the medium five times.  Cells 
were preincnbated for 15 min in medium alone or in medium containing  100 
lag/ml of CTB proteoglycan,  and were then washed three times by centrifuga- 
tion in medium. 
* Numbers are averages  +  mean deviations (n  =  2). 
cell-binding, proteoglycan-binding, and fibronectin-binding 
sites present in the intact molecule. The results on the behav- 
ior of cells after attaching  to  cytotactin-coated substrates 
have reconciled various disparate observations made in pre- 
vious studies.  They are consistent with the notion that the 
effects of cytotactin on cells in various contexts in vivo will 
depend on the local composition of the extracellular matrix; 
i.e., the presence of varying amounts of such cytotactin-bind- 
ing molecules as  fibronectin and  CTB proteoglycan.  The 
data on the binding properties permit the proposal of  a model 
of eytotactin relating its structure to its binding functions. 
The present studies show that cytotactin mediates cell at- 
tachment but, as noted previously (3, 40), it does not pro- 
mote cell spreading. In contrast, cell attachment to fibronec- 
tin substrates is routinely followed by the energy-dependent 
processes, cell spreading and formation of focal contacts (8, 
19, 29). Cell attachment to fibronectin, however, can be dis- 
sociated  from these  latter  steps.  Cells  attach  but  spread 
poorly either on  low  concentrations of fibronectin or on 
higher concentrations of fibronectin in the presence of high 
concentrations of collagen (20, 34). Cells attach and spread 
on substrates coated with fibronectin fragments that include 
the Arg-Gly-Asp recognition sequence. These cells will not 
form focal contacts, however, unless  the fibronectin frag- 
ments also include the heparin-binding domain of the mole- 
cule which interacts with integral cell-surface heparin sulfate 
proteoglycans  (29,  43).  Therefore,  while  cytotactin  and 
fibronectin have distinct effects on cell behavior in  vitro, 
their effects in vivo may overlap depending on the molecular 
context provided by the local composition of  the extracellular 
matrix and by the specific receptors available at the cell sur- 
face. Moreover, various modes of intermolecular binding be- 
tween cytotactin, fibronectin, and other matrix components 
may differentially modulate the effects of these molecules on 
cell behavior (23). 
The data on the effects of  cytotactin on the adhesion of neu- 
rons and glia to substrates emphasize the potential differ- 
ences in results that may be obtained depending on the choice 
of adhesion assay used. In an assay in which contact between 
cells and the substrate is initiated by gravity and may be sta- 
bilized by cell spreading, fibroblasts attached to cytotactin- 
coated substrates but remained rounded while neurons and 
glia did not attach to the substrate.  Indeed, cytotaetin in- 
hibited their attachment to other protein-coated substrates. 
However, neurons and glia did attach to cytotactin-coated 
substrates in an assay in which cell-substrate contact was 
driven by centrifugation. It appears,  therefore, that these 
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Cytotactin-coated  beads plus 
CTB proteoglycan-coated  beads 
Cytotactin-coated  beads plus 
fibronectin-coated  beads 
Superthreshold  Inhibition  Superthreshold  Inhibition 
Antibody  particles*  ( %  )  particles*  ( %  ) 
Nonimmune  16,900  -  18,100  - 
Anti-35 kD  4,400  74  1,100  94 
Anti-75 kD  16,100  5  17,900  1 
ID8  16,600  2  16,500  9 
M1  15,900  6  16,300  10 
Binding assays monitoring  the coaggregation  of microscopic  beads (Covaspheres)  coated with cytotactin  with Covaspheres  coated with other proteins  were per- 
formed as previously  described  (23, 24). Forms and amounts of antibodies  present during incubations  were as follows:  Fab' fragments  of rabbit IgG-nonimmune, 
50 Ixg; anti-35 kD, 10 Ixg; and anti-75 kD, 50 ~tg; Monocional  IgG-1D8, 25 gg; M1, 25 gg. 
* Average  of duplicate  points. In all cases, the mean deviation  was <2,000 superthreshold  particles.  Each  species  of bead, when incubated  alone, resulted  in < 1,000 
superthreshold particles. 
cells contain functional cell-surface receptors for cytotactin. 
The  apparent failure of these cells to attach to cytotactin- 
coated substrates may be due to a  transient binding of the 
molecule to these cells which results in global cell-surface 
modulation (11) and an inhibition of cell spreading. In turn, 
the failure to spread may block the further stabilization of 
cell attachment and,  in the case of neural crest cells (40), 
cause the slowing or inhibition of cell migration. The inhibi- 
tory effect of cytotactin on cell adhesion in in vitro assays 
may not have a precise counterpart in vivo. Cells that adhere 
to cytotactin in vivo may, for example, be able to spread be- 
cause they interact with other extracellular matrix compo- 
nents  and other cells in three dimensions.  Nonetheless, if 
cytotactin causes ceils to round up in vivo, it is likely that 
it will also inhibit in vivo cell migration at least to  some 
degree. 
The functional effects described above are obviously de- 
pendent on structural factors including the location and steric 
properties of the binding sites, the valence, and the shape of 
the molecule. It is, therefore, particularly important to locate 
the binding sites in the overall structure. Cytotactin is known 
to have a distinctive structure, appearing in electron micro- 
scopic images as a figure known as a hexabrachion with six 
arms emanating from  a  central core.  The integrity of this 
structure requires intact interchain disulfide bonds (see Table 
II). On the basis of this and other studies, we have formulated 
a model that summarizes our knowledge of the structure of 
cytotactin polypeptide chains  and  their  orientation  in  the 
hexabrachion (Fig. 8). In view of the findings that the molec- 
ular mass of a hexabrachion is approximately six times that 
of a  single chain of cytotactin and that hexabrachions have 
six indistinguishable arms in electron microscopic images, 
we assume that each polypeptide chain contributes to a single 
arm of the hexabrachion. In the proposed model, we have 
also assumed that each polypeptide in the hexabrachion is 
identical and has a molecular mass of 220 kD, the predomi- 
nant  species  in  the  cytotactin preparations  used  in  these 
studies.  Given the possibility that various cytotactins may 
arise from alternative RNA splicing events, it is possible that 
other cytotactin polypeptides are, in fact, a structural compo- 
nent of some hexabrachions. 
In the attempt to map the binding functions of the mole- 
cule, two groups of cytotactin fragments have been character- 
ized:  disulfide-bonded  oligomers  consisting  primarily  of 
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Figure 8. Proposed orientation of the fragments of cytotactin in a 
linear map of the molecule (top) and in a hexabrachion (bottom). 
Fraction I (solid boxes) includes the portion of the molecule where 
the polypeptide chains meet to form a hexabrachion and are linked 
by disulfide bonds. In addition, fraction I extends up the arms of 
the hexabrachion at least to the site (*) where monoclonal antibody 
MI binds (17, 42). Fraction II (open boxes) is located in the distal 
portion of the arms of the hexabrachion and contains a cell-binding 
site, a CTB proteoglycan-binding site, and a fibronectin-binding 
site. Fractions I and II are drawn to scale and are drawn with jagged 
ends to indicate that their precise locations in the molecule have not 
yet been determined. The 35-kD and 75-kD CNBr fragments of 
cytotactin (which have also been drawn to scale), the site of  the 1D8 
epitope (<>), and the sites of the HNK-I epitopes (vertical bars) 
have been placed at arbitrary positions within fractions I and II 
because their precise localizations within these structures have not 
yet been determined. For clarity, the positions of these features and 
the amino (N) and carboxyl (C) termini of the molecule have only 
been indicated on the linear model. The central globular region of 
the hexabrachion seen in electron micrographs has been left empty 
to indicate the possibility that fraction I may not extend into this 
structure. 
The Journal of Cell Biology, Volume 107, 1988  2338 100-KD polypeptides (fraction I), and a mixture of closely 
related 90- and 65-kD polypeptides (fraction II) that do not 
contain interchain disulfide bonds and that migrate as mono- 
mers during ultracentrifugation under nondenaturing condi- 
tions. Immunological and structural analyses suggested that 
the components in each fraction were related to the other 
components in the same fraction but not to the components 
in the other fraction. Because fraction I contains interchain 
disulfide bonds, it should include regions in the central por- 
tion of the molecule (Fig. 8) where the polypeptide chains 
meet. Consistent with this idea, the components in fraction 
I cross-reacted with a polyclonal antibody prepared against 
a 75-kD CNBr fragment of  cytotactin that is disulfide-bonded 
under native conditions. In addition, the material in fraction 
I must extend into the arms of the hexabrachion because it 
was  recognized by a  monoclonal antibody, M1,  known to 
bind to the proximal portion of the arms (17, 42). Fraction 
I also probably includes the majority of  the carbohydrate epi- 
topes recognized by monoclonal antibody HNK-1.  In con- 
trast, polypeptides in fraction II are monomeric and proba- 
bly correspond to portions of the free arms of the molecule 
(Fig. 8). Both components in this fraction were recognized 
by a polyclonal antibody prepared against a  35-kD CNBr 
fragment of cytotactin and the 90-kD component was recog- 
nized by monoclonal antibody 1D8; neither of these antibod- 
ies react with fraction I. Recent amino acid sequence analy- 
ses (Jones, F. S., S. Hoffman, B. A. Cunningham, and G. M. 
Edelman, unpublished observations) have suggested that the 
components in fraction I are amino-terminal to the compo- 
nents in fraction II. 
The proposed structural model of cytotactin and the results 
of  the binding assays performed here allow an initial localiza- 
tion  of various  functional  regions  in  cytotactin.  Several 
results indicate that a cell-binding region in cytotactin is lo- 
cated within fraction II and is, therefore, present in the arms 
of the hexabrachion. The data also suggest that a binding site 
for CTB proteoglycan is present in fraction II, and that when 
CTB proteoglycan is bound to fraction II, cell binding is in- 
hibited. These conclusions drawn from experiments involv- 
ing purified fraction II are supported and extended by the 
results of antibody perturbation experiments. The anti-35 
kD antibody cross-reacts with fraction II and not fraction I 
and completely inhibits the binding of cytotactin to cells, 
CTB proteoglycan, and fibronectin. In contrast, the anti-75 
kD antibody which specifically recognizes fraction I had no 
effect on any of these binding mechanisms. Given the rela- 
tively large stretch of polypeptide that might be blocked by 
attachment of an antibody molecule, it should not be con- 
cluded that all these binding sites are necessarily located on 
this single CNBr fragment of cytotactin. However, all three 
of these binding sites are likely to be located in the same 
general region of the molecule; i.e., the distal portion of the 
arms of the hexabrachion. In agreement with our results, a 
monoclonal antibody that inhibited the binding of tenascin 
to fibronectin was recently shown to bind to the ends of the 
arms  of the hexabrachion in electron microscopic images 
(3).  Indirect experiments also suggested that this antibody 
blocks a cell-binding site on tenascin. 
Recently, we have sequenced a cDNA clone coding for a 
contiguous sequence of 933 amino acids in cytotactin, or ap- 
proximately one-half the  molecule (26).  A  directly deter- 
mined amino-terminal sequence of a 22-kD CNBr fragment 
of the molecule recognized by monoclonal antibody 1D8 was 
found in the sequence deduced from the clone (26). There- 
fore, the 90-kD component of fraction II, which is also rec- 
ognized by  1D8, must overlap at least part of this 22-kD 
CNBr fragment. The deduced sequence of cytotactin (26) 
also contained the sequence Arg-Gly-Asp, which forms part 
of a  cell-binding  site  in fibronectin and  several other ex- 
tracellular proteins (25,  37).  The present observation that 
RGD-containing peptides inhibit the binding of fibroblasts to 
cytotactin or to fraction II suggests that a cell-binding site in 
fraction II of cytotactin contains an RGD sequence. Never- 
theless, this conclusion must remain provisional inasmuch as 
the available data are still not completely sufficient to prove 
that the known RGD sequence in cytotactin is present in the 
components in fraction II. 
The accumulated results on the structure and function of 
cytotactin suggest that this protein may be a natural media- 
tor of global cell-surface modulation (11); i.e.,  cytotactin, 
through multivalent interactions with its receptors, may elicit 
a  transmembrane  response  that  affects the  status  of the 
cytoskeleton, the mobility of cell surface proteins, and ulti- 
mately, cell behavior. The interesting possibility arises that 
cytotactin may affect fundamental processes of morphogene- 
sis and pattern formation by means of this mechanism. 
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